Research Focus

Former Employee. Medicine; Research Proj Coord

Recent additions – View all

1. Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience

   Meeting Abstract

   Smyth, E. C.; Enzinger, P. C.; Li, J.; Vincitore, M.; Lacy, J.; El-Rayes, B. F.; Kunz, P. L.; Ford, J. M.; Robinson, E.; Kelsen, D. P.; more...
   Journal of Clinical Oncology (2011)

   Fulltext@MSK | Save
2. Prognostic significance of human epidermal growth factor-2 (HER2) in advanced gastric cancer: A US and European international collaborative analysis

   Meeting Abstract

   Shah, M. A.; Janjigian, Y. Y.; Pauligk, C.; Werner, D.; Kelsen, D. P.; Jaeger, E.; Altmannsberger, H.; Robinson, E.; Tang, L. H.; Barbashina, V. V.; more...
   Journal of Clinical Oncology (2011)

   Fulltext@MSK | Save
3. Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)

   Meeting Abstract

   Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
   Journal of Clinical Oncology (2011)

   Fulltext@MSK | Save